Tag - ADTX

Markets

Dawson James cuts Aditxt Therapeutics PT to $1 from $6

Dawson James Securities slashed its price target for Aditxt Therapeutics (NASDAQ:ADTX) to $1 from $6, but maintained a “buy” rating, noting that cash is tight and a capital raise is expected. The stock closed at 17...

August 16, 2022

Markets

Dawson Jones starts Aditxt Therapeutics at buy; PT $14

Dawson Jones Securities initiated coverage of Aditxt Therapeutics (NASDAQ:ADTX) with a “buy” rating and $14 price target. The stock closed at $3.34 on Feb. 3. Aditxt has developed a unique antibody test that measures a...

February 4, 2021

Tag - ADTX

Dawson James cuts Aditxt Therapeutics PT to $1 from $6

Dawson Jones starts Aditxt Therapeutics at buy; PT $14

General

More